Jan A. Rosier, Mark A. Martens, Josse R. Thomas

Global New Drug Development (eBook, ePUB)

An Introduction

• Format: ePub

Produktbeschreibung

The development of new drugs is very complex, costly and risky. Its success is highly dependent on an intense collaboration and interaction between many departments within the drug development organization, external investigators and service providers, in constant dialogue with regulatory authorities, payers, academic experts, clinicians and patient organizations. Within the different phases of the drug life cycle, drug development is by far the most crucial part for the initial and continued success of a drug on the market. This book offers an introduction to the field of drug development with a clear overview of the different processes that lead to a successful new medicine and of the regulatory pathways that are used to launch a new drug that are both safe and efficacious. "e;This is the most comprehensive and detailed book on drug development I have ever read and I feel that it is likely to become a staple of drug development courses, such as those taught at Masters Level in my own University.... I think in the light of increasing integration of company and academic approaches to drug development both sides can read this book... (and, therefore)... this book could not be more timely."e; Professor Mike Coleman, University of Aston, UK ( from his review of the final manuscript)

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: John Wiley & Sons
• Seitenzahl: 424
• Erscheinungstermin: 3. Juli 2014
• Englisch
• ISBN-13: 9781118414859
• Artikelnr.: 41140525

Autorenporträt

Jan A. Rosier, Professor, Faculty of Pharmaceutical Sciences, University of Leuven/Cranfield, School of Management. Mark Martens, Belgium; Toxicologist. Josse Thomas, Belgium; Guest Profrssor Leuven and Université de Liège, Belgium).

Inhaltsangabe

Series Foreword ix Preface xi Acknowledgement xiii Abbreviations xv
Introduction xxi 1 Drug Life Cycle 1 1.1 Introduction 1 1.2 Drivers of the
search for a new drug 2 1.3 Structure of a drug life cycle 5 1.4 Costs and
risks of drug research and development 6 1.5 Risk of drug R&D 7 1.6 Value
for patient and society 9 1.7 The end of a drug's life 9 1.8 Management 10
References 10 2 Drug Discovery and Design 13 2.1 Introduction 13 2.2
Approaches in drug discovery 14 2.3 The drug discovery process 17
References 21 3 Drug Development: General Aspects 23 3.1 Introduction 23
3.2 The objective of drug development 23 3.3 Drug development organisations
and teams 24 3.4 Drug development streams 27 3.5 Phases in drug development
36 3.6 Regulatory environment 44 3.7 Quality management 58 3.8 Project risk
management 75 3.9 Ethical considerations 79 References 88 4 Methods and
Techniques Used in Drug Development 91 4.1 Introduction 91 4.2 Chemical and
pharmaceutical development 91 4.3 Non-clinical development 106 4.4 Clinical
development 139 References 166 5 The Early Development of a New Drug 169
5.1 Introduction 169 5.2 Preclinical phase 170 5.3 Clinical phase 200
References 251 6 The Late Development of a New Drug 253 6.1 Introduction
253 6.2 Pre-approval development 254 6.3 Marketing authorisation 316 6.4
Post-approval development 328 References 347 7 Special Drug Developments
351 7.1 Introduction 351 7.2 Development of orphan drugs 351 7.3 Paediatric
drug development 354 7.4 Geriatric drug development 356 7.5 Development of
fixed-dose drug combinations 358 7.6 Other special drug developments 360
References 360 8 Drug Commercialisation 361 8.1 Introduction 361 8.2 Market
access 363 8.3 Pharmaceutical marketing 370 8.4 Independent drug
information 382 8.5 Rational use of medicines 383 References 384 Epilogue
387 Index 391